You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 3, March 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Basic Science Seminars in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (92)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Cerebrovascular Disease
 •Epilepsy
 •Stroke
 •Alert me on articles by topic

Glutamate Transporters in Neurologic Disease

Nicholas J. Maragakis, MD; Jeffrey D. Rothstein, MD, PhD

Arch Neurol. 2001;58:365-370.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Glutamate is the primary excitatory amino acid neurotransmitter in the human brain. It is important in synaptic plasticity, learning, and development. Its activity at the synaptic cleft is carefully balanced by receptor inactivation and glutamate reuptake. When this balance is upset, excess glutamate can itself become neurotoxic.

The neurotoxic properties of glutamate were first demonstrated in 1957 by Lucas and Newhouse,1 who showed that systemic administration of glutamate to infant mice caused retinal degeneration. Over the last 4 decades, a direct correlation between the neuroexcitatory and neurotoxic properties of glutamate has been linked to activation of excitatory amino acid receptors.2, 3, 4, 5 This overactivation leads to an enzymatic cascade of events ultimately resulting in cell death.

Regulation of synaptic transmission and glutamate levels in the synaptic cleft is performed by glutamate transporters. Glutamate transport is a sodium- and potassium-coupled process that is capable . . . [Full Text of this Article]

HUMAN GLUTAMATE TRANSPORTERS

NEUROSCIENTIFIC STUDY OF GLUTAMATE TRANSPORTER DYSFUNCTION

GLUTAMATE TRANSPORT AND HUMAN DISEASE

Amyotrophic Lateral Sclerosis

Alzheimer Disease

Stroke/Ischemia

Epilepsy

APPLICATIONS FOR DIAGNOSIS

COMMENT

From the Department of Neurology, Johns Hopkins University, Baltimore, Md.

Corresponding author and reprints: Jeffrey D. Rothstein, Department of Neurology, Johns Hopkins University, Meyer 6-109, 600 N Wolfe St, Baltimore, MD 21287 (e-mail: jrothste@jhmi.edu).


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(3):523-525.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Selective defect of in vivo glycolysis in early Huntington's disease striatum
Powers et al.
Proc. Natl. Acad. Sci. USA 2007;104:2945-2949.
ABSTRACT | FULL TEXT  

Is Huntington's a Glutamine Storage Disease?
Brusilow
Neuroscientist 2006;12:300-304.
ABSTRACT  

Impaired Glutamate Transport in a Mouse Model of Tau Pathology in Astrocytes
Dabir et al.
J. Neurosci. 2006;26:644-654.
ABSTRACT | FULL TEXT  

Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
Shin et al.
J. Cell Biol. 2005;171:1001-1012.
ABSTRACT | FULL TEXT  

Antibiotics that protect the brain
Secko
CMAJ 2005;172:467-468.
FULL TEXT  

Rapid Trafficking of the Neuronal Glutamate Transporter, EAAC1: EVIDENCE FOR DISTINCT TRAFFICKING PATHWAYS DIFFERENTIALLY REGULATED BY PROTEIN KINASE C AND PLATELET-DERIVED GROWTH FACTOR
Fournier et al.
J. Biol. Chem. 2004;279:34505-34513.
ABSTRACT | FULL TEXT  

Cortical selective vulnerability in motor neuron disease: a morphometric study
Maekawa et al.
Brain 2004;127:1237-1251.
ABSTRACT | FULL TEXT  

In Vitro Ischemic Tolerance Involves Upregulation of Glutamate Transport Partly Mediated by the TACE/ADAM17-Tumor Necrosis Factor-{alpha} Pathway
Romera et al.
J. Neurosci. 2004;24:1350-1357.
ABSTRACT | FULL TEXT  

Molecular Abnormalities of the Glutamate Synapse in the Thalamus in Schizophrenia
MEADOR-WOODRUFF et al.
Ann. N. Y. Acad. Sci. 2003;1003:75-93.
ABSTRACT | FULL TEXT  

Functional characterization of a glutamate/aspartate transporter from the mosquito Aedes aegypti
Umesh et al.
J. Exp. Biol. 2003;206:2241-2255.
ABSTRACT | FULL TEXT  

Methylmercury Increases Glutamate Release from Brain Synaptosomes and Glutamate Uptake by Cortical Slices from Suckling Rat Pups: Modulatory Effect of Ebselen
Farina et al.
Toxicol Sci 2003;73:135-140.
ABSTRACT | FULL TEXT  

Retinal Glutamate Transporter Changes in Experimental Glaucoma and after Optic Nerve Transection in The Rat
Martin et al.
IOVS 2002;43:2236-2243.
ABSTRACT | FULL TEXT  

Mechanisms of neurodegeneration in amyotrophic lateral sclerosis
Cluskey and Ramsden
Mol. Pathol. 2001;54:386-392.
ABSTRACT | FULL TEXT  

Postmortem brain abnormalities of the glutamate neurotransmitter system in autism
Purcell et al.
Neurology 2001;57:1618-1628.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.